Key1 Capital

Activity from announced rounds

Activity in this selectionApr 30, 2025 · Apr 1, 2025

Key1 Capital is an Israeli growth-technology manager whose investment records identify Lyte, Remepy and Xsight.

Recorded funding activity

Lyte develops robotic perception systems. Remepy combines prescription medicines with therapeutic software, while Xsight designs connectivity chips for computing infrastructure. The companies pursue distinct hardware and healthcare products.

Sources
Rounds participated in
0
Confirmed lead rounds
—
All roles disclosed
New companies
0
First participation on record · 0 follow-on
Funding in participating rounds
—
0 disclosed · full round size, not this investor’s share

By stage

No activity in this selection.

By primary sector

No activity in this selection.

By country

No activity in this selection.

Rounds

0 in this selection

No rounds match this selection.